
|Articles|September 1, 2004
Alefacept's safety profile encouraging
New York - Recent data suggests that refinements in dosing techniques can improve clinical outcomes with alefacept (Amevive, Biogen).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
2
Dual-Action Microneedle Patch Shows Promise for Psoriasis in Preclinical Study
3
AI Analysis Reveals Menopausal Hair Loss Linked to Systemic Health and Inflammation
4
Health Canada Grants Priority Review to Birch Triterpenes for EB
5














